Ledger.Open graph →
SEC Form D · Amendment · filed December 24, 2015

Amplyx Pharmaceuticals, Inc

Offering
$49.2M
Sold
$23.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Ciara Kennedy · SAN DIEGO, CAExecEd Mathers · SAN DIEGO, CADirectorMichael Grey · SAN DIEGO, CAExec · DirectorMitchell Mutz · SAN DIEGO, CAExecElaine Heron · SAN DIEGO, CADirectorNiall Odonnell · SAN DIEGO, CADirectorCaroline Popper · Rockville, MDExecRaj Ganguly · San Mateo, CAExecMax Mcdermott · Tustin, CADirectorRowan Chapman · San Mateo, CAExec · DirectorRubina N. Toorawa · Ebene, O4DirectorDeborah Kilpatrick · San Mateo, CADirectorKaran Rai · ASHEVILLE, NCDirectorJulianne Y. Ramming · New York, NYExecLin-Lin Zhou · Shanghai, IsraelDirectorJames Ahn · Shanghai, IsraelDirectorChristopher T. Demetriou · Philadelphia, PAExecAllan M. Bernheimer · Trumbull, CTExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗